Core Insights - Exponent, Inc. reported a strong financial performance for the fourth quarter and fiscal year 2025, highlighting the resilience and diversification of its portfolio [2][3][6] Financial Performance - Total revenues for Q4 2025 increased by 7.8% to $147.4 million compared to $136.8 million in Q4 2024 [3] - Revenues before reimbursements rose by 4.5% to $129.4 million in Q4 2025 from $123.8 million in Q4 2024 [3] - Net income for Q4 2025 was $24.8 million, or $0.49 per diluted share, up from $23.6 million, or $0.46 per diluted share in Q4 2024 [4] - EBITDA for Q4 2025 increased to $34.7 million, representing 26.8% of revenues before reimbursements, compared to $31.2 million or 25.2% in Q4 2024 [5] Annual Financial Results - Total revenues for fiscal year 2025 grew by 4.2% to $582.0 million from $558.5 million in fiscal year 2024 [6] - Net income for fiscal year 2025 was $106.0 million, or $2.07 per diluted share, down from $109.0 million, or $2.11 per diluted share in fiscal year 2024 [7] - EBITDA for fiscal year 2025 was $148.1 million, or 27.6% of revenues before reimbursements, slightly down from $147.1 million or 28.4% in fiscal year 2024 [8] Business Segments - The engineering and other scientific segment accounted for 85% of revenues before reimbursements in Q4 2025, with a 7% increase compared to the prior year [10] - The environmental and health segment represented 15% of revenues before reimbursements in Q4 2025, experiencing a 5% decline due to one less week of activity compared to Q4 2024 [12] Business Outlook - The company anticipates high-single-digit revenue growth for fiscal year 2026, supported by strong market drivers and a proven operating model [13][16] - Exponent is well-positioned to deliver profitable growth as innovation accelerates and systems become more complex, leveraging its multidisciplinary expertise [13]